Education
About Us
Working with TipRanks
Follow Us
Theraclion SA (FR:ALTHE)
:ALTHE
ALTHE Stock Chart & Stats
€0.58
>-€0.01(-1.89%)
At close: 4:00 PM EST
€0.58
>-€0.01(-1.89%)
Day’s Range― - ―
52-Week Range€0.14 - €1.25
Previous CloseN/A
Volume3.75K
Average Volume (3M)166.24K
Market Cap
€27.75M
Enterprise ValueN/A
Total Cash (Recent Filing)€4.17M
Total Debt (Recent Filing)€1.30M
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Apr 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding47,057,285
10 Day Avg. Volume141,876
30 Day Avg. Volume166,244
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-133.83K
Price to Sales (P/S)18.38
P/FCF Ratio-5.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ALTHE FAQ
What was Theraclion SA’s price range in the past 12 months?
Theraclion SA lowest stock price was €0.14 and its highest was €1.25 in the past 12 months.
What is Theraclion SA’s market cap?
Theraclion SA’s market cap is €27.75M.
When is Theraclion SA’s upcoming earnings report date?
Theraclion SA’s upcoming earnings report date is Apr 23, 2026 which is in 174 days.
How were Theraclion SA’s earnings last quarter?
Theraclion SA released its earnings results on Oct 29, 2025. The company reported -€0.055 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.055.
Is Theraclion SA overvalued?
According to Wall Street analysts Theraclion SA’s price is currently Overvalued.
Does Theraclion SA pay dividends?
Theraclion SA does not currently pay dividends.
What is Theraclion SA’s EPS estimate?
Theraclion SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theraclion SA have?
Theraclion SA has 47,057,285 shares outstanding.
What happened to Theraclion SA’s price movement after its last earnings report?
Theraclion SA reported an EPS of -€0.055 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.221%.
Which hedge fund is a major shareholder of Theraclion SA?
Currently, no hedge funds are holding shares in FR:ALTHE
Company Description
Theraclion SA
Theraclion SA (ALTHE) is a French medical technology company specializing in the development and commercialization of echotherapy solutions. The company focuses on non-invasive ultrasound treatments for various medical conditions, primarily in the oncology and aesthetic markets. Theraclion's flagship product is the Echopulse system, which utilizes high-intensity focused ultrasound (HIFU) to treat tumors and other lesions without the need for surgical intervention.
Technical Analysis
MAUNA KEA TECHNOLOGIES
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Median Technologies
―
Implanet SA
―